Fundz

Vor Biopharma Inc. reported raising $110 Million in an initial SEC Form D filing, from an offering of $110 Million

PUBLIC · VORJul 10, 2020

Amount Raised

$110 Million

$110 Million sold, per SEC Form D (first sale Jul 10, 2020)

Round Type

Venture

CambridgeOtherBiotechnologyHealth CareTherapeutics

Quick answer

Vor Bio raised $110 Million in a funding round, dated July 10, 2020. Vor Bio is based in Cambridge, Massachusetts, United States.

How much did Vor Bio raise?
Vor Bio raised $110 Million in a funding round on July 10, 2020.
What does Vor Bio do?
Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases.
Where is Vor Bio based and how big is it?
Vor Bio is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at Vor Bio?
Fundz holds 2 contacts at Vor Bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Vor Bio that raised within 45 days of this round, from Fundz verified event records.

  • Cartesian Therapeutics, Inc. raised $25M on August 18, 2020.
  • Jade Biosciences raised $76M on August 14, 2020.
  • Dyne Therapeutics raised $116M on August 14, 2020.
  • Vaccinex raised $8M on August 11, 2020.
  • Korsana Biosciences raised $24M on August 11, 2020.
  • Biohaven raised $450M (Funding Round) on August 7, 2020.

Who to call at Vor Bio, and when

A new round usually means Vor Bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vor Bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vor Bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vor Bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vor Bio

Location

Cambridge, Massachusetts, United States

About

Vor Bio is a clinical-stage biotechnology company transforming the treatment of autoimmune diseases. The company is focused on rapidly advancing telitacicept, a novel dual-target fusion protein, through Phase 3 clinical development and commercialization to address serious autoantibody-driven conditions worldwide.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vor Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts6 people are listed at Vor Bio. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vor Bio's next move

See what Strategic adds

Vor Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.